Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Endocrinology

What Are the Side Effects of Acromegaly Radiation?

At a Glance

Radiation therapy for acromegaly can take 2 to 10 years to normalize hormone levels. The most common long-term risk is hypopituitarism, which is a gradual loss of healthy pituitary function that requires lifelong hormone replacement. Rare risks include vision changes and secondary tumors.

Radiation therapy is usually considered a third-line option for acromegaly, recommended when surgery and medications have not fully controlled your pituitary tumor or hormone levels [1][2]. If you and your doctor are discussing radiation, it is completely natural to worry about how it might affect your brain or your other hormones. Modern radiation techniques are highly precise, meaning the risk to the rest of your brain is very low [3]. However, radiation does carry a high risk of eventually causing damage to your healthy pituitary tissue, which can lead to new hormone deficiencies [4][5].

How Radiation Works and The Timeline

Unlike surgery, which physically removes the tumor, radiation works by damaging the DNA of the tumor cells, stopping them from growing and slowly reducing their ability to produce excess growth hormone [1]. Because of this, radiation does not work immediately. It typically takes years—often anywhere from 2 to 10 years—for growth hormone and IGF-1 levels to fully normalize [6][7].

During this “waiting period,” you will likely need to continue taking medications to control your acromegaly symptoms [8]. To find out if the radiation has finally worked, your endocrinologist will periodically pause your medications for a short time and test your blood. If your levels remain normal without the medication, the radiation has been successful.

There are two main types of modern, highly focused radiation used for acromegaly [9]:

  • Stereotactic Radiosurgery (SRS): (such as Gamma Knife or CyberKnife) This delivers a high dose of radiation in a single, highly targeted session. To ensure absolute precision, you will be fitted with a custom mesh mask or a specialized head frame to keep your head perfectly still during the procedure. It is often preferred for smaller tumors that are not too close to the optic nerves [7][10].
  • Fractionated Stereotactic Radiotherapy (FSRT): This delivers the radiation in smaller doses over several weeks, usually using a custom-fit mask. It is often used when the tumor is larger or sits dangerously close to critical structures like the optic chiasm (the pathway for your vision) [11][12].

Both SRS and FSRT have similar high rates of successfully stopping tumor growth, but they both carry long-term risks that you must be prepared for [13][9].

The High Risk of Hypopituitarism

The most common long-term side effect of pituitary radiation is hypopituitarism, which is the loss of normal pituitary function [14][5]. Even with the most precise targeting, the healthy pituitary tissue surrounding the tumor absorbs some radiation, and this tissue is very sensitive to damage [15].

This damage usually does not happen right away. Instead, hormone production slowly declines over several years [16]. While some studies show that about 15% of patients develop new hormone deficiencies within the first 10 years [4], the risk is cumulative and continues to climb steadily as decades pass [17][6]. Over your lifetime, the likelihood of developing at least one new hormone deficiency is very high. You may eventually develop panhypopituitarism, where the gland stops making most or all of its hormones [18].

If this happens, it is entirely manageable, but it requires lifelong hormone replacement therapy [6]. In practical terms, this usually means taking a few daily pills or using patches to replace your thyroid, adrenal, and reproductive hormones. (Growth hormone replacement is rarely needed for acromegaly patients unless they become profoundly deficient). Because this decline happens so gradually, you will need regular, long-term blood tests to monitor your hormone levels for the rest of your life [6][19].

Rare but Serious Risks: Vision, Blood Vessels, and Secondary Tumors

Because modern radiation is so precise, generalized brain damage is not expected [20]. However, you should be aware of a few rare but serious risks:

  • Optic Nerve Damage: The optic nerves, which control your vision, run directly above the pituitary gland. While modern techniques have made visual deterioration uncommon, there is a very small risk of radiation-induced optic neuropathy (damage to the vision nerves) [3][21].
  • Vascular Issues: Radiation can sometimes affect the blood vessels near the pituitary gland, slightly increasing the long-term risk of carotid artery stenosis (narrowing of the arteries) or stroke years down the line [22][23].
  • Secondary Tumors: There is a very small, but real, risk that the radiation could cause a different type of tumor (such as a meningioma) to form in the treated area decades later [24][25]. Because this risk persists for 30 years or more, lifelong MRI monitoring is essential [26][27].
  • Cognitive Changes: Severe cognitive decline is not typical with focal radiation. However, some patients may experience mild, long-lasting changes, such as slight issues with short-term or anterograde memory [28][20].

Common questions in this guide

How long does it take for radiation therapy to work for acromegaly?
Unlike surgery, radiation does not work immediately. It typically takes anywhere from 2 to 10 years for growth hormone and IGF-1 levels to fully normalize as the tumor cells are slowly damaged. You will need to take medication during this waiting period.
What is the most common side effect of radiation for pituitary tumors?
The most common long-term side effect is hypopituitarism, which is a gradual loss of normal pituitary function. This happens slowly over many years and often eventually requires taking daily pills or patches for lifelong hormone replacement.
Will I need to keep taking acromegaly medication after radiation?
Yes, you will likely need to continue your medications during the waiting period while the radiation slowly takes effect. Your endocrinologist will periodically pause the medication to check if your hormone levels remain normal without it.
Can radiation for acromegaly cause vision loss?
Because the optic nerves run directly above the pituitary gland, there is a very small risk of radiation-induced optic nerve damage. However, modern radiation techniques are highly precise, making visual deterioration uncommon.
What is the difference between single-session radiosurgery and fractionated therapy?
Single-session stereotactic radiosurgery (SRS) delivers a high dose of radiation in one targeted treatment. Fractionated stereotactic radiotherapy (FSRT) delivers smaller doses over several weeks, which is often used for larger tumors or those dangerously close to the optic nerves.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the size and location of my tumor, do you recommend single-session radiosurgery (SRS) or fractionated therapy (FSRT)?
  2. 2.How often will we temporarily pause my acromegaly medications to check if the radiation has taken full effect?
  3. 3.How close is my tumor to my optic chiasm, and how will you protect my vision during treatment?
  4. 4.What early symptoms should I watch out for that might indicate a new hormone deficiency?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Will My Face and Hands Go Back to Normal After Acromegaly?How Does Acromegaly Affect Fertility and Pregnancy?Does Acromegaly Cause Severe Headaches? Causes & ReliefDoes Acromegaly Cause Jaw Changes and Malocclusion?Does Acromegaly Cause Joint Pain? Is It Reversible?Does Acromegaly Cause Voice Changes & Vocal Thickening?How Are Acromegaly Medications Administered?How Is Transsphenoidal Surgery for Acromegaly Performed?Is Acromegalic Cardiomyopathy Reversible?Is Acromegaly Hereditary? Genetic Causes ExplainedAcromegaly and Anesthesia: What Are the Airway Risks?What Are the Second-Line Treatments for Acromegaly?What does the Knosp grade mean on a pituitary MRI?GH vs IGF-1 in Acromegaly: What is the Difference?What Is the Life Expectancy for Acromegaly Patients?Why Do Acromegaly Patients Need Frequent Colonoscopies?Why is Gadolinium Contrast Used for Pituitary MRIs?Why Monitor IGF-1 Instead of Growth Hormone on PegvisomantWhy is an Oral Glucose Tolerance Test Used for Acromegaly?

References

References (28)
  1. 1

    Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly.

    Losa M, Resmini E, Barzaghi LR, et al.

    Clinical endocrinology 2021; (95(6)):849-855 doi:10.1111/cen.14547.

    PMID: 34219264
  2. 2

    Repeat gamma knife radiosurgery for recurrent pituitary adenomas.

    Losa M, Albano L, Prandino E, et al.

    Journal of endocrinological investigation 2025; (48(7)):1589-1595 doi:10.1007/s40618-025-02564-x.

    PMID: 40111591
  3. 3

    Safety and efficacy of multisession gamma knife radiosurgery for residual or recurrent pituitary adenomas.

    Albano L, Losa M, Nadin F, et al.

    Endocrine 2019; (64(3)):639-647 doi:10.1007/s12020-019-01876-2.

    PMID: 30798432
  4. 4

    Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency.

    Dumot C, Mantziaris G, Dayawansa S, et al.

    Neuro-oncology 2024; (26(4)):715-723 doi:10.1093/neuonc/noad215.

    PMID: 38095431
  5. 5

    Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study.

    Cordeiro D, Xu Z, Mehta GU, et al.

    Journal of neurosurgery 2019; (131(4)):1188-1196 doi:10.3171/2018.5.JNS18509.

    PMID: 31369225
  6. 6

    Stereotactic radiosurgery for recurrent/residual nonfunctioning pituitary adenoma: a single-arm systematic review and meta-analysis.

    De Nigris Vasconcellos F, Vilela MAD, Garcia Torrico F, et al.

    Acta neurochirurgica 2024; (166(1)):392 doi:10.1007/s00701-024-06296-4.

    PMID: 39356336
  7. 7

    Stereotactic radiosurgery for acromegaly: an international systematic review and meta-analysis of clinical outcomes.

    Singh R, Didwania P, Lehrer EJ, et al.

    Journal of neuro-oncology 2020; (148(3)):401-418 doi:10.1007/s11060-020-03552-2.

    PMID: 32506372
  8. 8

    Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study.

    Ding D, Mehta GU, Patibandla MR, et al.

    Neurosurgery 2019; (84(3)):717-725 doi:10.1093/neuros/nyy178.

    PMID: 29757421
  9. 9

    Outcomes for Pituitary Adenoma Patients Treated with Linac- Based Stereotactic Radiosurgery and Radiotherapy: a Long Term Experience in Thailand.

    Puataweepong P, Dhanachai M, Hansasuta A, et al.

    Asian Pacific journal of cancer prevention : APJCP 2015; (16(13)):5279-84 doi:10.7314/apjcp.2015.16.13.5279.

    PMID: 26225666
  10. 10

    Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study.

    Taylor DG, Janssen A, Ding D, et al.

    Neurosurgery 2020; (86(5)):656-664 doi:10.1093/neuros/nyz245.

    PMID: 31384920
  11. 11

    Early Versus Delayed Fractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma.

    Sathe AV, Siu A, Kang KC, et al.

    World neurosurgery 2023; (180()):e317-e323 doi:10.1016/j.wneu.2023.09.067.

    PMID: 37757941
  12. 12

    The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma.

    Puataweepong P, Dhanachai M, Hansasuta A, et al.

    Technology in cancer research & treatment 2016; (15(6)):NP10-NP15 doi:10.1177/1533034615607113.

    PMID: 26424501
  13. 13

    Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis.

    Li X, Li Y, Cao Y, et al.

    Journal of the neurological sciences 2017; (372()):110-116 doi:10.1016/j.jns.2016.11.024.

    PMID: 28017195
  14. 14

    Potentially radiation-induced late toxicity after irradiation of pituitary adenoma, a retrospective dosimetric study.

    Hemaidia RM, Cebula H, Goichot B, Noel G

    Radiation oncology (London, England) 2025; (21(1)):5 doi:10.1186/s13014-025-02751-3.

    PMID: 41339912
  15. 15

    Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis.

    Palmisciano P, Ogasawara C, Ogasawara M, et al.

    Pituitary 2022; (25(3)):404-419 doi:10.1007/s11102-022-01219-x.

    PMID: 35349010
  16. 16

    Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience.

    Lamba N, Bussiere MR, Niemierko A, et al.

    Practical radiation oncology 2019; (9(3)):e266-e273 doi:10.1016/j.prro.2019.01.009.

    PMID: 30731274
  17. 17

    Long-term radiographic and endocrinological outcomes of stereotactic radiosurgery for recurrent or residual nonfunctioning pituitary adenomas.

    Shaaban A, Dumot C, Mantziaris G, et al.

    Journal of neurosurgery 2024; (141(3)):773-780 doi:10.3171/2024.1.JNS232285.

    PMID: 38518285
  18. 18

    Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management.

    Faraj CA, McCutcheon IE

    Journal of neuro-oncology 2026; (178(2)).

    PMID: 42250176
  19. 19

    Management of Hypopituitarism.

    Alexandraki KI, Grossman A

    Journal of clinical medicine 2019; (8(12)) doi:10.3390/jcm8122153.

    PMID: 31817511
  20. 20

    Stereotactic radiosurgery and fractionated radiation therapy in the management of pituitary tumors.

    Mantziaris G, Trifiletti DM, Pikis S, Sheehan JP

    Neuro-oncology advances 2025; (7(Suppl 1)):i58-i68 doi:10.1093/noajnl/vdae010.

    PMID: 40718388
  21. 21

    Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.

    Milano MT, Grimm J, Soltys SG, et al.

    International journal of radiation oncology, biology, physics 2021; (110(1)):87-99 doi:10.1016/j.ijrobp.2018.01.053.

    PMID: 29534899
  22. 22

    Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas.

    Chang CL, Yuan KS, Wu ATH, Wu SY

    Cancers 2019; (11(11)) doi:10.3390/cancers11111658.

    PMID: 31717774
  23. 23

    Percutaneous transluminal angioplasty in a patient with internal carotid artery stenosis following gamma knife radiosurgery for recurrent pituitary adenoma.

    Ito H, Onodera H, Sase T, et al.

    Surgical neurology international 2015; (6(Suppl 7)):S279-83 doi:10.4103/2152-7806.157795.

    PMID: 26069850
  24. 24

    Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.

    Follin C, Erfurth EM

    Current treatment options in oncology 2016; (17(9)):50 doi:10.1007/s11864-016-0426-0.

    PMID: 27476159
  25. 25

    Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.

    Withrow DR, Anderson H, Armstrong GT, et al.

    JAMA oncology 2022; (8(12)):1756-1764 doi:10.1001/jamaoncol.2022.4425.

    PMID: 36201196
  26. 26

    Meningioma after radiotherapy for malignancy.

    Morgenstern PF, Shah K, Dunkel IJ, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016; (30()):93-97 doi:10.1016/j.jocn.2016.02.002.

    PMID: 27068012
  27. 27

    Radiation-Induced Meningiomas: An Exhaustive Review of the Literature.

    Yamanaka R, Hayano A, Kanayama T

    World neurosurgery 2017; (97()):635-644.e8 doi:10.1016/j.wneu.2016.09.094.

    PMID: 27713063
  28. 28

    Neurocognitive changes in pituitary adenoma patients after Gamma Knife radiosurgery.

    Tooze A, Sheehan JP

    Journal of neurosurgery 2018; (129(Suppl1)):55-62.

    PMID: 30544290

This page is for informational purposes only and does not replace professional medical advice. Always discuss radiation risks, treatment timelines, and long-term side effects with your endocrinologist or radiation oncologist.

Get notified when new evidence is published on Acromegaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.